Interview: Ersin Erfa – CEO, Centurion – Turkey
The CEO of Centurion shares his ambitious vision for the company’s expansion into plasma products, biotech,…
Centurion – Turkey
Last updated: 27.07.2015
Centurion Pharma began its journey in 1949 and now, in cooperation with important organizations of the world, it imports products directed towards use in treatment of rarely encountered diseases of Turkey, as well as biological, biotechnological products, hospital instruments and vaccines which are today’s modern treatment alternatives.
Centurion Pharma, which believes that every patient deserves modern treatment alternatives and a high quality of life, established its R&D department in 2011 and ever since, it has taken a giant step in order for specific and special products to be manufactured in our country.
Centurion Pharma embraces respect for the human being, nature and the homeland as its core values and, as one of the leading firms in the sector with its flexible, creative, competitive and job-oriented structure, it acts responsibly and will continue to aim for higher targets in the future.
Contact Details
Adress : Hoşsohbet sk. No:6 Balmumcu/Beşiktaş/İstanbul
Pho : +90 212 275 07 08
Pho : +90 212 275 07 09
Fax : +90 212 274 61 49
Mail : info@centurion.com.tr
Interviews
Related
SeokHoon Kang – General Manager Turkey, Celltrion Healthcare
Best known as the company that launched the world’s first “antibody biosimilar,” Celltrion is looking to…
Evren Özlu – General Manager, Boehringer Ingelheim Turkey
Evren Özlü, General Manager of Turkey and Sub-Saharan Africa at Boehringer Ingelheim, discusses the company’s…
Ufuk Kumrulu – Chairman, Polifarma
Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu,…
Turkey / A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has…
Burak Dağlıoğlu – President, Investment Office of the Presidency of the…
The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines…
Muzzafer Bal – CEO, Ali Raif
Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a…
Turkey / Abdi Ibrahim CEO Talks Biosimilars, M&A, & US Entry
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…
Hatice Öncel – CEO, Ilko Pharmaceuticals
Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel…
Hamdi Akan – Head of the Executive Board, Clinical Research Association,…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and…
Ismail Yormaz – VP & Regional Director South-East, Recordati
Ismail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has…
Turkey / How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of…
Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey…
